Document Detail

Human malignant glioma cell lines are refractory to retinoic acid-mediated differentiation and sensitization to apoptosis.
MedLine Citation:
PMID:  10878446     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Retinoids are candidate differentiation-inducing agents for glial tumors. Differentiation therapy is an attractive approach to cancers that resist surgery, irradiation and chemotherapy. METHODS: We examined the effects of retinoids on proliferation, morphology and sensitivity to apoptosis in human malignant glioma and neuroblastoma cell lines. RESULTS: In contrast to neuroblastoma cells, retinoids are devoid of acute cytotoxic effects and have only moderate antiproliferative effects on human glioma cell lines upon long-term exposure at high concentrations. Electron microscopy fails to reveal features of differentiation or apoptosis in retinoid-treated glioma cells and untransformed rat astrocytes. Retinoids do not modulate CD95 or CD95L expression or susceptibility to CD95-mediated apoptosis and fail to act in synergy with interferon (IFN)-alpha or IFN-gamma or cancer chemotherapy drugs to promote growth inhibition or apoptosis. CONCLUSION: Glioma cell lines are refractory to the induction of differentiation or apoptosis by retinoids.
F Schmidt; P Groscurth; J Dichgans; M Weller
Related Documents :
19156866 - All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in pc12 cells: role ...
14592536 - Distinct role and functional mode of tr3 and raralpha in mediating atra-induced signall...
11527146 - Cepharanthine activates caspases and induces apoptosis in jurkat and k562 human leukemi...
11776436 - L-2,5-dihydrophenylalanine, an inducer of cathepsin-dependent apoptosis in human promye...
19144696 - Cytokine-induced f-actin reorganization in endothelial cells involves rhoa activation.
20160166 - Apoptosis induced by jak2 inhibition is mediated by bim and enhanced by the bh3 mimetic...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology     Volume:  10     ISSN:  1015-8987     ISO Abbreviation:  Cell. Physiol. Biochem.     Publication Date:  2000  
Date Detail:
Created Date:  2000-10-19     Completed Date:  2000-10-19     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9113221     Medline TA:  Cell Physiol Biochem     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  159-68     Citation Subset:  IM    
Copyright Information:
Copyright 2000 S. Karger AG, Basel.
Laboratory of Molecular Neuro-Oncology, Department of Neurology, University of Tübingen, School of Medicine, Tübingen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Astrocytes / drug effects
Cell Differentiation
Drug Interactions
Glioma / drug therapy*,  pathology
Interferon-alpha / pharmacology
Interferon-gamma / pharmacology
Proto-Oncogene Proteins c-bcl-2 / metabolism
Tretinoin / pharmacology*
Tumor Suppressor Protein p53 / metabolism
Reg. No./Substance:
0/Interferon-alpha; 0/Proto-Oncogene Proteins c-bcl-2; 0/Tumor Suppressor Protein p53; 302-79-4/Tretinoin; 82115-62-6/Interferon-gamma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Expression of galectin-3 in cells exposed to stress-roles of jun and NF-kappaB.
Next Document:  Nitric oxide production by pre-implantation embryos in response to embryotoxic factors.